Completed
The COVID-19 response has exposed gaps in pandemic preparedness and revealed opportunities to enhance global vaccine development by leveraging novel technologies and streamlining research efforts. At the request of the U.S. Department of Health and Human Services’ Office of Global Affairs, the National Academies will convene a committee to develop recommendations to optimize vaccine research and development for future seasonal and pandemic influenza events.
Featured publication
Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response: Lessons from COVID-19
Consensus Study Report
·2022
The global response to COVID-19 has demonstrated the importance of vigilance and preparedness for infectious diseases, particularly influenza. There is a need for more effective influenza vaccines and modern manufacturing technologies that are adaptable and scalable to meet demand during a pandemic....
View details